New stock news | Jia Zhi Technology's Hong Kong IPO prospectus is invalid
Zhejiang Gazi Technology Co., Ltd. (hereinafter referred to as "Gazi Technology") submitted its Hong Kong IPO prospectus on January 23, 2026 and it expired after 6 months on July 23, 2026. Zhongjin Company was its exclusive sponsor.
Zhejiang JiaZhi Technology Co., Ltd. (referred to as JiaZhi Technology) submitted its Hong Kong IPO prospectus on January 23, 2026, which expired after 6 months on July 23, 2026, with CICC as its exclusive sponsor.
The prospectus shows that JiaZhi Technology is a global expert in intelligent mobile Siasun Robot & Automation, dedicated to achieving full-scenario applications of Siasun Robot & Automation in different environments, industries, and tasks. JiaZhi Technology has strong commercialization capabilities to support the large-scale delivery and deployment of intelligent mobile Siasun Robot & Automation, integrated systems, and industry-specific solutions.
According to data from Zhushi Consulting, as of January 16, 2026, based on order amounts, the company has become one of the top ten global intelligent mobile Siasun Robot & Automation companies. In the field of industrial intelligent mobile Siasun Robot & Automation, based on order amounts, the company has become one of the top five global companies and top three in China according to Zhushi Consulting data.
Related Articles
A-share market midday review: Multiple factors affecting the market! The index fell on shrinking volume, the Science and Technology Innovation 50 Index dropped more than 4%, and semiconductor stocks fell across the board.
Haisco Pharmaceutical Group (002653.SZ): Innovative drug Amber Acid Sipukawan tablets approved for market launch.
HK Stock Market Move | AKESO (09926) rises by nearly 6% as the global phase III HARMONi study on OS updates, showing highly consistent therapeutic effects in both Eastern and Western populations.
A-share market midday review: Multiple factors affecting the market! The index fell on shrinking volume, the Science and Technology Innovation 50 Index dropped more than 4%, and semiconductor stocks fell across the board.
Haisco Pharmaceutical Group (002653.SZ): Innovative drug Amber Acid Sipukawan tablets approved for market launch.
HK Stock Market Move | AKESO (09926) rises by nearly 6% as the global phase III HARMONi study on OS updates, showing highly consistent therapeutic effects in both Eastern and Western populations.
RECOMMEND
